Sfoglia per Rivista
Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia
2017-01-01 Gugliotta, Gabriele*; Castagnetti, Fausto; Breccia, Massimo; Albano, Francesco; Iurlo, Alessandra; Intermesoli, Tamara; Abruzzese, Elisabetta; Levato, Luciano; D’Adda, Mariella; Pregno, Patrizia; Cavazzini, Francesco; Stagno, Fabio; Martino, Bruno; La Barba, Gaetano; Sorà, Federica; Tiribelli, Mario; Bigazzi, Catia; Binotto, Gianni; Bonifacio, Massimiliano; Caracciolo, Clementina; Soverini, Simona; Foà, Robin; Cavo, Michele; Martinelli, Giovanni; Pane, Fabrizio; Saglio, Giuseppe; Baccarani, Michele; Rosti, Gianantonio
Increasing serum transferrin to reduce tissue iron overload due to ineffective erythropoiesis
2015-01-01 Tolosano, Emanuela
Infants with acute myeloid leukemia treated according to the Associazione Italiana di Ematologia e Oncologia Pediatrica 2002/01 protocol have an outcome comparable to that of older children
2014-01-01 Masetti, Riccardo*; Rondelli, Roberto; Fagioli, Franca; Mastronuzzi, Angela; Pierani, Paolo; Togni, Marco; Menna, Giuseppe; Pigazzi, Martina; Putti, Maria Caterina; Basso, Giuseppe; Pession, Andrea; Locatelli, Franco
INHIBITION OF USP7 INDUCES GROWTH ARREST AND APOPTOSIS VIA PTEN IN CLL CELLS
2015-01-01 G. Carrà, C. Panuzzo, D. Torti, G. Parvis, S. Crivellaro, A. Guerrasio, G. Saglio, A. Morotti
INHIBITION OF USP7 INDUCES SELECTIVE CANCER CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA THROUGH PTEN AND INDEPENDENTLY FROM P53 STATUS
2016-01-01 G Carrà, C Panuzzo, S Crivellaro, D Torti, G Parvis, U Familiari, M Volante, D Morena, MF Lingua, M Brancaccio, A Guerrasio, PP Pandolfi, G Saglio, R Taulli, A Morotti
Interactions between RPS19, mutated in Diamond-Blackfan anemia, and the PIM-1 oncoprotein
2005-01-01 CHIOCCHETTI A; GIBELLO L; CARANDO A; ASPESI A; SECCO P; GARELLI E; LORENI F; ANGELINI M; BIAVA A; DAHL N; DIANZANI U; RAMENGHI U; SANTORO C; DIANZANI I
INTERMEDIATE-DOSE MELPHALAN (100MG/M2), THALIDOMIDE, DEXAMETHASONE AND STEM CELL SUPPORT IN PATIENTS WITH REFRACTORY OR RELAPSED MYELOMA
2006-01-01 P. Musto; I. Avonto; P.R. Scalzulli; B. Bruno; A. Falcone; M.T. Ambrosini; S. Bringhen; F. Gay; C. Rus; F. Cavallo; P. Falco; M. Massaia; M. Boccadoro; A. Palumbo
INTERPHASE FLUORESCENCE IN SITU HYBRIDIZATION (FISH) DETEDTION OF CHROMOSOME 13 ABNORMALITIES (DEL 13) IN MULTIPLE MYELOMA
2003-01-01 Omedè P; Ruggeri M; Falco P; Beggiato E; Brunetti M; Cavallo F; Bertola A; Bringhen S; Morrone F; Giaretta F; Ghignone R; Palumbo A; Bruno B; Boccadoro M
Intrauterine growth restriction and genetic predisposition to thrombophilia.
2004-01-01 FRANCHI F.; CETIN I.; T. TODROS; ANTONAZZO P.; NOBILE DE SANTIS MS.; CARDAROPOLI S.; BUCCIARELLI P.; BIGUZZI E.
Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood.
2001-01-01 MARESCHI K ;BIASIN E ;PIACIBELLO W ;AGLIETTA M ;MADON E ;FAGIOLI F
Italian blood donors with anti-HBc and occult hepatitis B virus infection
2007-01-01 Paola Manzini; Mauro Girotto; Raffaele Borsotti; Osvaldo Giachino; Roberto Guaschino; Maurizio Lanteri; Domenico Testa; Paola Ghiazza; Maria Vacchini; Franca Danielle; Alessandra Pizzi; Chiara Valpreda; Franco Castagno; Franco Curti; Paola Magistroni; Maria Lorena Abate; Antonina Smedile; Mario Rizzetto
Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders
2008-01-01 Angelucci E; Barosi G; Camaschella C; Cappellini MD; Cazzola M; Galanello R; Marchetti M; Piga A; Tura S.
JAK2V617F mutation and allele burden: correlation with morphologic and clinical features and response to therapy in patients with essential thrombocytemia.
2010-01-01 L. Riera L; Sismondi F; Tondat F; Beggiato E; Schinco P; Nicolino B; Godio L; Francia di Celle P; Pich A.
Juvenile hemochromatosis associated with B-thalassemia treated by phlebotomy and recombinant human erythropoietin.
2000-01-01 DE GOBBI M; PASQUERO P; BRUNELLO F; PACCOTTI P; MAZZA U; CAMASCHELLA C.
Key concepts and critical issues on epoetin and filgrastim biosimilars. A position paper from the Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation
2011-01-01 Barosi G; Bosi A; Abbracchio MP; Danesi R; GENAZZANI, Armando; Corradini P; Pane F; Tura S.
[Kinetic and immunological studies in human myeloma: clinical implications (author's transl)]
1979-01-01 PILERI A ;BOCCADORO M
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study
2019-01-01 Ferrero, Simone; Rossi, Davide; Rinaldi, Andrea; Bruscaggin, Alessio; Spina, Valeria; Eskelund, Christian W; Evangelista, Andrea; Moia, Riccardo; Kwee, Ivo; Dahl, Christina; Di Rocco, Alice; Stefoni, Vittorio; Diop, Fary; Favini, Chiara; Ghione, Paola; Mahmoud, Abdurraouf Mokhtar; Schipani, Mattia; Kolstad, Arne; Barbero, Daniela; Novero, Domenico; Paulli, Marco; Zamò, Alberto; Jerkeman, Mats; Gomez da Silva, Maria; Santoro, Armando; Molinari, Annalia; Ferreri, Andres; Grønbæk, Kirsten; Piccin, Andrea; Cortelazzo, Sergio; Bertoni, Francesco; Ladetto, Marco; Gaidano, Gianluca
Late deaths among five-year survivors of childhood cancer. A population-based study in Piedmont Region, Italy.
2006-01-01 DAMA E ;PASTORE G ;MOSSO ML ;FERRANTE D ;MAULE MM ;MAGNANI C ;MERLETTI F
LDH AS PREDICTIVE PARAMETER IN TREATMENT-NAIVE PATIENTS WITH TRISOMY 12 CHRONIC LYMPHOCYTIC LEUKEMIA
2017-01-01 Autore, F; Strati, P; Innocenti, I; Corrente, F; Trentin, L; Cortelezzi, A; Visco, C; Coscia, M; Cuneo, A; Gozzetti, A; Mauro, FR; Montillo, M; Gentile, M; Morabito, F; Molica, S; Falcucci, P; D'Arena, G; Murru, R; Vincelli, D; Galieni, P; Reda, G; Tisi, MC; Vitale, C; Rigolin, GM; Ferrajoli, A; Laurenti, L
LDH AS PREDICTIVE PARAMETER IN TREATMENT-NAIVE PATIENTS WITH TRISOMY 12 CHRONIC LYMPHOCYTIC LEUKEMIA
2017-01-01 Autore, F; Strati, P; Innocenti, I; Corrente, F; Trentin, L; Cortelezzi, A; Visco, C; Coscia, M; Cuneo, A; Gozzetti, A; Mauro, FR; Montillo, M; Gentile, M; Morabito, F; Molica, S; Falcucci, P; D'Arena, G; Murru, R; Vincelli, D; Galieni, P; Reda, G; Tisi, MC; Vitale, C; Rigolin, GM; Ferrajoli, A; Laurenti, L
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia | 2017 | Gugliotta, Gabriele*; Castagnetti, Fausto; Breccia, Massimo; Albano, Francesco; Iurlo, Alessandra; Intermesoli, Tamara; Abruzzese, Elisabetta; Levato, Luciano; D’Adda, Mariella; Pregno, Patrizia; Cavazzini, Francesco; Stagno, Fabio; Martino, Bruno; La Barba, Gaetano; Sorà, Federica; Tiribelli, Mario; Bigazzi, Catia; Binotto, Gianni; Bonifacio, Massimiliano; Caracciolo, Clementina; Soverini, Simona; Foà, Robin; Cavo, Michele; Martinelli, Giovanni; Pane, Fabrizio; Saglio, Giuseppe; Baccarani, Michele; Rosti, Gianantonio | |
| Increasing serum transferrin to reduce tissue iron overload due to ineffective erythropoiesis | 2015 | Tolosano, Emanuela | |
| Infants with acute myeloid leukemia treated according to the Associazione Italiana di Ematologia e Oncologia Pediatrica 2002/01 protocol have an outcome comparable to that of older children | 2014 | Masetti, Riccardo*; Rondelli, Roberto; Fagioli, Franca; Mastronuzzi, Angela; Pierani, Paolo; Togni, Marco; Menna, Giuseppe; Pigazzi, Martina; Putti, Maria Caterina; Basso, Giuseppe; Pession, Andrea; Locatelli, Franco | |
| INHIBITION OF USP7 INDUCES GROWTH ARREST AND APOPTOSIS VIA PTEN IN CLL CELLS | 2015 | G. Carrà, C. Panuzzo, D. Torti, G. Parvis, S. Crivellaro, A. Guerrasio, G. Saglio, A. Morotti | |
| INHIBITION OF USP7 INDUCES SELECTIVE CANCER CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA THROUGH PTEN AND INDEPENDENTLY FROM P53 STATUS | 2016 | G Carrà, C Panuzzo, S Crivellaro, D Torti, G Parvis, U Familiari, M Volante, D Morena, MF Lingua, M Brancaccio, A Guerrasio, PP Pandolfi, G Saglio, R Taulli, A Morotti | |
| Interactions between RPS19, mutated in Diamond-Blackfan anemia, and the PIM-1 oncoprotein | 2005 | CHIOCCHETTI A; GIBELLO L; CARANDO A; ASPESI A; SECCO P; GARELLI E; LORENI F; ANGELINI M; BIAVA A; DAHL N; DIANZANI U; RAMENGHI U; SANTORO C; DIANZANI I | |
| INTERMEDIATE-DOSE MELPHALAN (100MG/M2), THALIDOMIDE, DEXAMETHASONE AND STEM CELL SUPPORT IN PATIENTS WITH REFRACTORY OR RELAPSED MYELOMA | 2006 | P. Musto; I. Avonto; P.R. Scalzulli; B. Bruno; A. Falcone; M.T. Ambrosini; S. Bringhen; F. Gay; C. Rus; F. Cavallo; P. Falco; M. Massaia; M. Boccadoro; A. Palumbo | |
| INTERPHASE FLUORESCENCE IN SITU HYBRIDIZATION (FISH) DETEDTION OF CHROMOSOME 13 ABNORMALITIES (DEL 13) IN MULTIPLE MYELOMA | 2003 | Omedè P; Ruggeri M; Falco P; Beggiato E; Brunetti M; Cavallo F; Bertola A; Bringhen S; Morrone F; Giaretta F; Ghignone R; Palumbo A; Bruno B; Boccadoro M | |
| Intrauterine growth restriction and genetic predisposition to thrombophilia. | 2004 | FRANCHI F.; CETIN I.; T. TODROS; ANTONAZZO P.; NOBILE DE SANTIS MS.; CARDAROPOLI S.; BUCCIARELLI P.; BIGUZZI E. | |
| Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood. | 2001 | MARESCHI K ;BIASIN E ;PIACIBELLO W ;AGLIETTA M ;MADON E ;FAGIOLI F | |
| Italian blood donors with anti-HBc and occult hepatitis B virus infection | 2007 | Paola Manzini; Mauro Girotto; Raffaele Borsotti; Osvaldo Giachino; Roberto Guaschino; Maurizio Lanteri; Domenico Testa; Paola Ghiazza; Maria Vacchini; Franca Danielle; Alessandra Pizzi; Chiara Valpreda; Franco Castagno; Franco Curti; Paola Magistroni; Maria Lorena Abate; Antonina Smedile; Mario Rizzetto | |
| Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders | 2008 | Angelucci E; Barosi G; Camaschella C; Cappellini MD; Cazzola M; Galanello R; Marchetti M; Piga A; Tura S. | |
| JAK2V617F mutation and allele burden: correlation with morphologic and clinical features and response to therapy in patients with essential thrombocytemia. | 2010 | L. Riera L; Sismondi F; Tondat F; Beggiato E; Schinco P; Nicolino B; Godio L; Francia di Celle P; Pich A. | |
| Juvenile hemochromatosis associated with B-thalassemia treated by phlebotomy and recombinant human erythropoietin. | 2000 | DE GOBBI M; PASQUERO P; BRUNELLO F; PACCOTTI P; MAZZA U; CAMASCHELLA C. | |
| Key concepts and critical issues on epoetin and filgrastim biosimilars. A position paper from the Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation | 2011 | Barosi G; Bosi A; Abbracchio MP; Danesi R; GENAZZANI, Armando; Corradini P; Pane F; Tura S. | |
| [Kinetic and immunological studies in human myeloma: clinical implications (author's transl)] | 1979 | PILERI A ;BOCCADORO M | |
| KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study | 2019 | Ferrero, Simone; Rossi, Davide; Rinaldi, Andrea; Bruscaggin, Alessio; Spina, Valeria; Eskelund, Christian W; Evangelista, Andrea; Moia, Riccardo; Kwee, Ivo; Dahl, Christina; Di Rocco, Alice; Stefoni, Vittorio; Diop, Fary; Favini, Chiara; Ghione, Paola; Mahmoud, Abdurraouf Mokhtar; Schipani, Mattia; Kolstad, Arne; Barbero, Daniela; Novero, Domenico; Paulli, Marco; Zamò, Alberto; Jerkeman, Mats; Gomez da Silva, Maria; Santoro, Armando; Molinari, Annalia; Ferreri, Andres; Grønbæk, Kirsten; Piccin, Andrea; Cortelazzo, Sergio; Bertoni, Francesco; Ladetto, Marco; Gaidano, Gianluca | |
| Late deaths among five-year survivors of childhood cancer. A population-based study in Piedmont Region, Italy. | 2006 | DAMA E ;PASTORE G ;MOSSO ML ;FERRANTE D ;MAULE MM ;MAGNANI C ;MERLETTI F | |
| LDH AS PREDICTIVE PARAMETER IN TREATMENT-NAIVE PATIENTS WITH TRISOMY 12 CHRONIC LYMPHOCYTIC LEUKEMIA | 2017 | Autore, F; Strati, P; Innocenti, I; Corrente, F; Trentin, L; Cortelezzi, A; Visco, C; Coscia, M; Cuneo, A; Gozzetti, A; Mauro, FR; Montillo, M; Gentile, M; Morabito, F; Molica, S; Falcucci, P; D'Arena, G; Murru, R; Vincelli, D; Galieni, P; Reda, G; Tisi, MC; Vitale, C; Rigolin, GM; Ferrajoli, A; Laurenti, L | |
| LDH AS PREDICTIVE PARAMETER IN TREATMENT-NAIVE PATIENTS WITH TRISOMY 12 CHRONIC LYMPHOCYTIC LEUKEMIA | 2017 | Autore, F; Strati, P; Innocenti, I; Corrente, F; Trentin, L; Cortelezzi, A; Visco, C; Coscia, M; Cuneo, A; Gozzetti, A; Mauro, FR; Montillo, M; Gentile, M; Morabito, F; Molica, S; Falcucci, P; D'Arena, G; Murru, R; Vincelli, D; Galieni, P; Reda, G; Tisi, MC; Vitale, C; Rigolin, GM; Ferrajoli, A; Laurenti, L |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile